The infectious diseases market in US to grow at a CAGR of 3.37% over the period 2014-2019

1
Infectious Diseases Market in US 2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast 2019
Published Date Jun 2015
2
Report Description
About Infectious Diseases Human beings are prone
to various kinds of infections. Infectious
diseases are caused by various pathogenic
microorganisms such as bacteria, fungi,
parasites, and viruses. Antimicrobials are used
to treat infections. They act by killing or
resisting the growth of the microorganisms. They
either act via the host defense system or
directly target the causative agent. Based on the
target organism, antimicrobials can be classified
into anti-bacterial, anti-viral, anti-fungal, and
anti-parasitic drugs. The infectious diseases
market in US to grow at a CAGR of 3.37 over the
period 2014-2019. Get Complete Report
At http//www.bigmarketresearch.com/infectious-di
seases-in-us-2015-2019-market Covered in this
Report This report covers the present scenario
and the growth prospects of the infectious
diseases market in US for the period 2015-2019.
To calculate the market size, the report
considers revenue generated through the sales of
drugs administered to treat infectious diseases
caused by bacteria, viruses, fungi, and
parasites.
3
Report Description
The report presents the vendor landscape and a
corresponding detailed analysis of the top
vendors in the infectious diseases market in US.
In addition, it discusses the major drivers that
influence the growth of the market. It also
outlines the challenges faced by the vendors and
the market at large, as well as the key trends
that are emerging in the market. Infectious
Diseases Market in US 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. In addition,
it discusses the major drivers that influence the
growth of the market, challenges faced by the
vendors and the market at large, as well as the
key trends that contribute to the growth the
market. Enquire About this report
http//www.bigmarketresearch.com/report-enquiry/25
0553 Key Vendors F. Hoffmann-La Roche
Gilead Sciences GlaxoSmithKline Johnson
Johnson Merck Pfizer
4
Report Description
Other Prominent Vendors AbbVie Astellas
Pharma AstraZeneca Bayer Bristol-Myers
Squibb Chimerix Pharmaceuticals Cubist Eli
Lilly Isis Pharmaceuticals Mitsubishi Tanabe
Pharma Novartis Sanofi Vertex Market
Driver Rise in patient population For a full,
detailed list, view our report
5
Report Description
Market Challenge Generic erosion For a full,
detailed list, view our report Market Trend
Emergence of IFN-free therapies For a full,
detailed list, view our report Key Questions
Answered in this Report What will the market
size be in 2019 and what will the growth rate
be? What are the key market trends? What is
driving this market? What are the challenges to
market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by the key vendors? What are
the strengths and weaknesses of the key vendors?
6
Table of Contents
01.Executive Summary 02.List of
Abbreviations 03.Scope of the Report 04.Market
Research Methodology 05. Introduction 06. Market
Landscape 07. Epidemiology 08. Market
Segmentation by Type of Drug 09. Market
Segmentation by Route of Administration 10.
Buying Criteria 11. Market Growth Drivers 12.
Drivers and their Impact 13. Market
Challenges 14. Impact of Drivers and
Challenges 15. Market Trends 16. Trends and their
Impact 17. Vendor Landscape
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/infectious-diseas
es-in-us-2015-2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com